Chantix Does Not Increase Depression Risk? A Pfizer Inc. Study Says Yes

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Faced with declining sales of its controversial Chantix quit-smoking pill, Pfizer has undertaken various educational and promotional efforts to revive its fortunes. And as part of the plan, the drugmaker funded a study that found people with a history of depression were no more likely to become depressed or have suicidal thoughts than those given a placebo.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC